Efficacy and Adverse Events of Apatinib Salvage Treatment for Refractory Diffuse Malignant Peritoneal Mesothelioma: A Pilot Study

por Yang, Zhi-Ran, Su, Yan-Dong, Ma, Ru, Wu, He-Liang, Li, Yan
Publicado 2022

NPM2 in malignant peritoneal mesothelioma: from basic tumor biology to clinical medicine

por Wu, He-liang, Yang, Zhi-ran, Yan, Li-jun, Su, Yan-dong, Ma, Ru, Li, Yan
Publicado 2022

Loss of NPM2 expression is a potential immunohistochemical marker for malignant peritoneal mesothelioma: a single-center study of 92 cases

por Wu, He-liang, Yang, Zhi-ran, Su, Yan-dong, Ma, Ru, Du, Xue-mei, Gao, Ying, Li, Yan
Publicado 2022

Long-term survival in patients with PMP: a single-institutional retrospective study from China

por Yang, Rui, Fu, Yu-Bin, Li, Xin-Bao, Ma, Ru, Su, Yan-Dong, Wu, He-Liang, Liang, Xin-Li, Li, Yan
Publicado 2023

Etiological analysis of infection after CRS + HIPEC in patients with PMP

por Yang, Rui, Zhao, Xin, Fu, Yu-Bin, Lin, Yu-Lin, Ma, Ru, Su, Yan-Dong, Wu, He-Liang, Liang, Xin-Li, Li, Yan
Publicado 2023